Prostate cancer vaccine: Preliminary Phase I/II data

Preliminary data from a dose-escalation, U.K. Phase I/II trial showed that 13 of 20 evaluable patients had antibody responses to MMG's Genvax immunostimulant, which is a component of the DNA vaccine. ...